Header Logo

Meenakshi Jolly

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentRheumatology
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7004391081

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Arora S, Block JA, Nika A, Sequeira W, Katz P, Jolly M. Does higher quality of care in systemic lupus erythematosus translate to better patient outcomes? Lupus. 2023 May; 32(6):771-780. PMID: 37121602.
      Citations:    
    2. Arora S, Katz P, Nika A, Sequeira W, Block JA, Yazdany J, Yelin E, Jolly M. Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life? Arthritis Care Res (Hoboken). 2023 06; 75(6):1198-1205. PMID: 35792677.
      Citations:    
    3. Jolly M, Katz P. Predictors of stress in patients with Lupus. Front Med (Lausanne). 2022; 9:986968. PMID: 36250087.
      Citations:    
    4. Han JY, Cho SK, Nam E, Kim H, Lee SS, Jolly M, Sung YK. Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus. Lupus. 2022 Oct; 31(12):1498-1507. PMID: 36017605.
      Citations:    
    5. Arora S, Nika A, Sequeira W, Block JA, Jolly M. Pneumococcal Vaccination Among Lupus Patients: Who Are the Recipients? J Clin Rheumatol. 2021 Dec 01; 27(8):e456-e461. PMID: 32804752.
      Citations:    
    6. Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, Devilliers H, Inoue M, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Clarke A, Weisman M, Wallace D, Mok CC. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798. PMID: 34304629.
      Citations:    
    7. Annapureddy N, Jolly M. Patient-Reported Outcomes in Lupus. Rheum Dis Clin North Am. 2021 08; 47(3):351-378. PMID: 34215368.
      Citations:    
    8. Pinto B, Dhooria A, Grover S, Jolly M, Raj JM, Sharma A. Fatigue and its correlates in Indian patients with systemic lupus erythematosus. Clin Rheumatol. 2021 Mar; 40(3):905-911. PMID: 33033858.
      Citations:    
    9. Azizoddin DR, Jolly M, Arora S, Yelin E, Katz P. Longitudinal Study of Fatigue, Stress, and Depression: Role of Reduction in Stress Toward Improvement in Fatigue. Arthritis Care Res (Hoboken). 2020 10; 72(10):1440-1448. PMID: 31421030.
      Citations:    
    10. Elkaraly NE, Nasef SI, Omar AS, Fouad AM, Jolly M, Mohamed AE. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients. Lupus. 2020 Nov; 29(13):1727-1735. PMID: 32878556.
      Citations:    
    11. Ganguli SK, Hui-Yuen JS, Jolly M, Cerise J, Eberhard BA. Performance and psychometric properties of lupus impact tracker in assessing patient-reported outcomes in pediatric lupus: Report from a pilot study. Lupus. 2020 Nov; 29(13):1781-1789. PMID: 32838619.
      Citations:    
    12. Jolly M, Sethi B, O'Brien C, Sequeira W, Block JA, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Cicognani E, Mazzoni D, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Mok CC, Clarke A, Weisman M, Wallace D. Drivers of Satisfaction With Care for Patients With Lupus. ACR Open Rheumatol. 2019 Dec; 1(10):649-656. PMID: 31872187.
      Citations:    
    13. Azizoddin DR, Jolly M, Arora S, Yelin E, Katz P. Patient-Reported Outcomes Predict Mortality in Lupus. Arthritis Care Res (Hoboken). 2019 08; 71(8):1028-1035. PMID: 30144293.
      Citations:    
    14. T?th DM, Ocsk? T, Balog A, Markovics A, Mikecz K, Kov?cs L, Jolly M, Bukiej AA, Ruthberg AD, Vida A, Block JA, Glant TT, Rauch TA. Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine. Arthritis Rheumatol. 2019 08; 71(8):1265-1275. PMID: 30835944.
      Citations:    
    15. Lillis TA, Tirone V, Gandhi N, Weinberg S, Nika A, Sequeira W, Hobfoll SE, Block JA, Jolly M. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care Res (Hoboken). 2019 03; 71(3):406-412. PMID: 29726637.
      Citations:    
    16. Hassan S, Smith MM, Block JA, Jolly M. Challenges to Practicing Rheumatology in an Academic Center. Rheum Dis Clin North Am. 2019 02; 45(1):27-37. PMID: 30447744.
      Citations:    
    17. Azizoddin DR, Gandhi N, Weinberg S, Sengupta M, Nicassio PM, Jolly M. Fatigue in systemic lupus: the role of disease activity and its correlates. Lupus. 2019 Feb; 28(2):163-173. PMID: 30580659.
      Citations:    
    18. Jolly M, Sequeira W, Block JA, Toloza S, Bertoli A, Blazevic I, Vila LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Mok CC, Weisman M, Clarke AE, Wallace D, Alarc?n G. Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2019 12; 71(12):1647-1652. PMID: 29693320.
      Citations:    
    19. Arora S, Nika A, Trupin L, Abraham H, Block J, Sequeira W, Yazdany J, Jolly M. Does Systemic Lupus Erythematosus Care Provided in a Lupus Clinic Result in Higher Quality of Care Than That Provided in a General Rheumatology Clinic? Arthritis Care Res (Hoboken). 2018 12; 70(12):1771-1777. PMID: 29609210.
      Citations:    
    20. Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clin Pharmacol Ther. 2019 08; 106(2):374-382. PMID: 30079582.
      Citations:    
    21. Gandhi N, Arora S, Sengupta M, Sequeira W, Jolly M, Block JA. Validation of SIMPLE Index for Lupus Disease Activity. J Clin Rheumatol. 2018 Sep; 24(6):313-318. PMID: 29517552.
      Citations:    
    22. Bhattacharya J, Pappas K, Toz B, Aranow C, Mackay M, Gregersen PK, Doumbo O, Traore AK, Lesser ML, McMahon M, Utset T, Silverman E, Levy D, McCune WJ, Jolly M, Wallace D, Weisman M, Romero-Diaz J, Diamond B. Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus. Mol Med. 2018 06 01; 24(1):24. PMID: 30134810.
      Citations:    
    23. Annapureddy N, Giangreco D, Devilliers H, Block JA, Jolly M. Psychometric properties of MDHAQ/RAPID3 in patients with systemic lupus erythematosus. Lupus. 2018 May; 27(6):982-990. PMID: 29451066.
      Citations:    
    24. Iwamoto T, Dorschner J, Jolly M, Huang X, Niewold TB. Associations between type I interferon and antiphospholipid antibody status differ between ancestral backgrounds. Lupus Sci Med. 2018; 5(1):e000246. PMID: 29387437.
      Citations:    
    25. Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Van Vollenhoven R, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clin Pharmacol Ther. 2018 06; 103(6):1074-1082. PMID: 28925027.
      Citations:    
    26. Azizoddin DR, Weinberg S, Gandhi N, Arora S, Block JA, Sequeira W, Jolly M. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus. Lupus. 2018 Apr; 27(5):728-737. PMID: 29087259.
      Citations:    
    27. Jolly M, Toloza S, Goker B, Clarke AE, Navarra SV, Wallace D, Weisman M, Mok CC. Disease-specific quality of life in patients with lupus nephritis. Lupus. 2018 Feb; 27(2):257-264. PMID: 28728507.
      Citations:    
    28. Kugasia A, Sehgal N, Dollear M, Sequeira W, Block JA, Jolly M. Practice patterns in longitudinal lupus care provision: patient and physician perspectives. Lupus. 2017 Dec; 26(14):1556-1561. PMID: 28659044.
      Citations:    
    29. Jolly M, Katz P. Systemic lupus erythematosus: The promise of PROMIS - is it ready for prime time in SLE? Nat Rev Rheumatol. 2017 08; 13(8):453-454. PMID: 28660907.
      Citations:    
    30. Brandt JE, Drenkard C, Kan H, Bao G, Dunlop-Thomas C, Pobiner B, Chang DJ, Jolly M, Lim SS. External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017 06; 69(6):842-848. PMID: 27564570.
      Citations:    
    31. Faridi MH, Khan SQ, Zhao W, Lee HW, Altintas MM, Zhang K, Kumar V, Armstrong AR, Carmona-Rivera C, Dorschner JM, Schnaith AM, Li X, Ghodke-Puranik Y, Moore E, Purmalek M, Irizarry-Caro J, Zhang T, Day R, Stoub D, Hoffmann V, Khaliqdina SJ, Bhargava P, Santander AM, Torroella-Kouri M, Issac B, Cimbaluk DJ, Zloza A, Prabhakar R, Deep S, Jolly M, Koh KH, Reichner JS, Bradshaw EM, Chen J, Moita LF, Yuen PS, Li Tsai W, Singh B, Reiser J, Nath SK, Niewold TB, Vazquez-Padron RI, Kaplan MJ, Gupta V. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283. PMID: 28263189.
      Citations:    
    32. Azizoddin DR, Olmstead R, Cost C, Jolly M, Ayeroff J, Racaza G, Sumner LA, Ormseth S, Weisman M, Nicassio PM. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus. Lupus. 2017 Aug; 26(9):967-974. PMID: 28059025.
      Citations:    
    33. Inoue M, Shiozawa K, Yoshihara R, Yamane T, Shima Y, Hirano T, Jolly M, Makimoto K. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus. 2017 Jul; 26(8):849-856. PMID: 27927882.
      Citations:    
    34. Devilliers H, Bonithon-Kopp C, Jolly M. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index. Lupus. 2017 Apr; 26(4):396-402. PMID: 27587460.
      Citations:    
    35. Annapureddy N, Devilliers H, Jolly M. Patient-reported outcomes in lupus clinical trials with biologics. Lupus. 2016 Sep; 25(10):1111-21. PMID: 27497256.
      Citations:    
    36. Antony A, Kandane-Rathnayake RK, Ko T, Boulos D, Hoi AY, Jolly M, Morand EF. Validation of the Lupus Impact Tracker in an Australian patient cohort. Lupus. 2017 Jan; 26(1):98-105. PMID: 27516435.
      Citations:    
    37. Jolly M, Kosinski M, Garris CP, Oglesby AK. Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016 06; 68(6):1422-31. PMID: 26814452.
      Citations:    
    38. Jolly M, Galicier L, Auma?tre O, Franc?s C, Le Guern V, Liot? F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DL, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacr? K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Hulot JS, Arora S, Amoura Z, Piette JC, Costedoat-Chalumeau N. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels. Lupus. 2016 Jun; 25(7):735-40. PMID: 26876692.
      Citations:    
    39. Giangreco D, Devilliers H, Annapureddy N, Block JA, Jolly M. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus. Lupus. 2015 Dec; 24(14):1486-91. PMID: 26162686.
      Citations:    
    40. Jolly M, Thakkar A, Mikolaitis RA, Block JA. Caregiving, dyadic quality of life and dyadic relationships in lupus. Lupus. 2015 Aug; 24(9):918-26. PMID: 25661509.
      Citations:    
    41. Mok CC, Kosinski M, Ho LY, Chan KL, Jolly M. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 Feb; 67(2):297-304. PMID: 25156199.
      Citations:    
    42. Jolly M, Sequeira W, Block JA. Health and quality of life outcomes. Health Qual Life Outcomes. 2014 Dec 12; 12:173. PMID: 25495461.
      Citations:    
    43. Jolly M, Peters KF, Mikolaitis R, Evans-Raoul K, Block JA. Body image intervention to improve health outcomes in lupus: a pilot study. J Clin Rheumatol. 2014 Dec; 20(8):403-10. PMID: 25417675.
      Citations:    
    44. Khan SQ, Guo L, Cimbaluk DJ, Elshabrawy H, Faridi MH, Jolly M, George JF, Agarwal A, Gupta V. A Small Molecule ?2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy. Front Med (Lausanne). 2014; 1:45. PMID: 25593918.
      Citations:    
    45. Castrej?n I, Tani C, Jolly M, Huang A, Mosca M. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol. 2014 Sep-Oct; 32(5 Suppl 85):S-85-95. PMID: 25365095.
      Citations:    
    46. Jolly M, Garris CP, Mikolaitis RA, Jhingran PM, Dennis G, Wallace DJ, Clarke A, Dooley MA, Parke A, Strand V, Al?rcon GS, Kosinski M. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2014 Oct; 66(10):1542-50. PMID: 24757021.
      Citations:    
    47. Bourr?-Tessier J, Clarke AE, Kosinski M, Mikolaitis-Preuss RA, Bernatsky S, Block JA, Jolly M. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus. 2014 Dec; 23(14):1452-9. PMID: 25081500.
      Citations:    
    48. Jolly M, Francis S, Aggarwal R, Mikolaitis RA, Niewold TB, Chubinskaya S, Block JA, Scanzello C, Sequeira W. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus. Lupus. 2014 Aug; 23(9):881-8. PMID: 24786785.
      Citations:    
    49. Dua AB, Touma Z, Toloza S, Jolly M. Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep. 2013 Dec; 15(12):380. PMID: 24178589.
      Citations:    
    50. Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013 Sep; 19(6):334-40. PMID: 23965484.
      Citations:    
    51. Chrabot BS, Kariuki SN, Zervou MI, Feng X, Arrington J, Jolly M, Boumpas DT, Reder AT, Goulielmos GN, Niewold TB. Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Genes Immun. 2013 Dec; 14(8):471-8. PMID: 23965942.
      Citations:    
    52. Kaya A, Goker B, Cura ES, Tezcan ME, Tufan A, Mercan R, Bitik B, Haznedaroglu S, Ozturk MA, Mikolaitis-Preuss RA, Block JA, Jolly M. Turkish lupusPRO: cross-cultural validation study for lupus. Clin Rheumatol. 2014 Aug; 33(8):1079-84. PMID: 23934384.
      Citations:    
    53. Bourr?-Tessier J, Clarke AE, Mikolaitis-Preuss RA, Kosinski M, Bernatsky S, Block JA, Jolly M. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol. 2013 Aug; 40(8):1327-33. PMID: 23772082.
      Citations:    
    54. Moldovan I, Cooray D, Carr F, Katsaros E, Torralba K, Shinada S, Ishimori M, Jolly M, Wilson A, Wallace D, Weisman M, Nicassio P. Pain and depression predict self-reported fatigue/energy in lupus. Lupus. 2013 Jun; 22(7):684-9. PMID: 23660302.
      Citations:    
    55. Jolly M, Toloza S, Block J, Mikolaitis R, Kosinski M, Wallace D, Durran-Barragan S, Bertoli A, Blazevic I, Vil? L, Cooray D, Moldovan I, Katsaros E, Weisman M, Torralba KM, Alarc?n G. Spanish LupusPRO: cross-cultural validation study for lupus. Lupus. 2013 Apr; 22(5):431-6. PMID: 23554032.
      Citations:    
    56. Navarra SV, Tanangunan RM, Mikolaitis-Preuss RA, Kosinski M, Block JA, Jolly M. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines. Lupus. 2013 Mar; 22(3):262-7. PMID: 23340995.
      Citations:    
    57. Jolly M, Kazmi N, Mikolaitis RA, Sequeira W, Block JA. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures. J Am Acad Dermatol. 2013 Apr; 68(4):618-623. PMID: 23107310.
      Citations:    
    58. Dua AB, Aggarwal R, Mikolaitis RA, Sequeira W, Block JA, Jolly M. Rheumatologists' quality of care for lupus: comparison study between a university and county hospital. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1261-4. PMID: 22392683.
      Citations:    
    59. Koldobskaya Y, Ko K, Kumar AA, Agik S, Arrington J, Kariuki SN, Franek BS, Kumabe M, Utset TO, Jolly M, Skol AD, Niewold TB. Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus. Clin Dev Immunol. 2012; 2012:682018. PMID: 22988468.
      Citations:    
    60. Jolly M, Pickard AS, Mikolaitis RA, Cornejo J, Sequeira W, Cash TF, Block JA. Body image in patients with systemic lupus erythematosus. Int J Behav Med. 2012 Jun; 19(2):157-64. PMID: 21380770.
      Citations:    
    61. Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 Aug; 42(1):56-65. PMID: 22480408.
      Citations:    
    62. Jolly M, Pickard AS, Sequeira W, Wallace DJ, Solem CT, Mikolaitis RA, Fogg L, Weisman MH, Block JA, Cash TF. A brief assessment tool for body image in systemic lupus erythematosus. Body Image. 2012 Mar; 9(2):279-84. PMID: 22154813.
      Citations:    
    63. Agik S, Franek BS, Kumar AA, Kumabe M, Utset TO, Mikolaitis RA, Jolly M, Niewold TB. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. J Rheumatol. 2012 Jan; 39(1):73-8. PMID: 22045845.
      Citations:    
    64. Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA, Jolly M, Utset TO, Niewold TB. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:802581. PMID: 22131818.
      Citations:    
    65. Moldovan I, Katsaros E, Carr FN, Cooray D, Torralba K, Shinada S, Ishimori ML, Jolly M, Wallace DJ, Weisman MH, Nicassio PM. The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus. 2011 Oct; 20(12):1285-92. PMID: 21813589.
      Citations:    
    66. Toloza SM, Sequeira W, Jolly M. Treatment of lupus: impact on quality of life. Curr Rheumatol Rep. 2011 Aug; 13(4):324-37. PMID: 21633837.
      Citations:    
    67. Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M, Mikolaitis RA, Guerrero G, Utset TO, Drevlow BE, Zaacks LS, Grober JS, Cohen LM, Kirou KA, Crow MK, Jolly M, Niewold TB. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-a and serologic autoimmunity in lupus patients. J Immunol. 2011 Aug 01; 187(3):1298-303. PMID: 21705624.
      Citations:    
    68. Aggarwal R, Sequeira W, Kokebie R, Mikolaitis RA, Fogg L, Finnegan A, Plaas A, Block JA, Jolly M. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):891-8. PMID: 21312346.
      Citations:    
    69. Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL, Utset TO, Jolly M, James JA, Harley JB, Niewold TB. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53. PMID: 21162028.
      Citations:    
    70. Carr FN, Nicassio PM, Ishimori ML, Moldovan I, Katsaros E, Torralba K, Shinada S, Cooray D, Wallace DJ, Finck S, Jolly M, Wilson AL, Weisman MH. Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 2011 Jan; 20(1):80-4. PMID: 20937622.
      Citations:    
    71. Jolly M, Pickard SA, Mikolaitis RA, Rodby RA, Sequeira W, Block JA. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol. 2010 Sep; 37(9):1828-33. PMID: 20716659.
      Citations:    
    72. Jolly M. Pitfalls and opportunities in measuring patient outcomes in lupus. Curr Rheumatol Rep. 2010 Aug; 12(4):229-36. PMID: 20425520.
      Citations:    
    73. Toloza SM, Jolly M, Alarc?n GS. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010 Aug; 12(4):237-49. PMID: 20461481.
      Citations:    
    74. Kariuki SN, Franek BS, Kumar AA, Arrington J, Mikolaitis RA, Utset TO, Jolly M, Crow MK, Skol AD, Niewold TB. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther. 2010; 12(4):R151. PMID: 20659327.
      Citations:    
    75. Kariuki SN, Franek BS, Mikolaitis RA, Utset TO, Jolly M, Skol AD, Niewold TB. Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients. J Biomed Biotechnol. 2010; 2010:826434. PMID: 20671926.
      Citations:    
    76. Lodolce JP, Kolodziej LE, Rhee L, Kariuki SN, Franek BS, McGreal NM, Logsdon MF, Bartulis SJ, Perera MA, Ellis NA, Adams EJ, Hanauer SB, Jolly M, Niewold TB, Boone DL. African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J Immunol. 2010 Jun 15; 184(12):7001-9. PMID: 20483768.
      Citations:    
    77. Jolly M, Mikolaitis RA, Shakoor N, Fogg LF, Block JA. Education, zip code-based annualized household income, and health outcomes in patients with systemic lupus erythematosus. J Rheumatol. 2010 Jun; 37(6):1150-7. PMID: 20360192.
      Citations:    
    78. Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M, Utset TO, Niewold TB. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 2010 Feb; 62(2):553-61. PMID: 20112359.
      Citations:    
    79. Jolly M, Pickard AS, Wilke C, Mikolaitis RA, Teh LS, McElhone K, Fogg L, Block J. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2010 Jan; 69(1):29-33. PMID: 19126561.
      Citations:    
    80. Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009 Jun; 36(6):1209-16. PMID: 19369452.
      Citations:    
    81. Mody S, Jolly M, Kwasny MJ, Block JA. Patient reported outcomes and analgesia use in osteoarthritis of the knee. Osteoarthritis Cartilage. 2008 Nov; 16(11):1294-9. PMID: 18456521.
      Citations:    
    82. Jolly M, Hill A, Mataria M, Agarwal S. Influence of an interactive joint model injection workshop on physicians' musculoskeletal procedural skills. J Rheumatol. 2007 Jul; 34(7):1576-9. PMID: 17516616.
      Citations:    
    83. Govindappa V, Hicks S, Wichter M, Jolly M. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus. Arthritis Rheum. 2007 Mar 15; 57(2):352-4. PMID: 17330286.
      Citations:    
    84. Jolly M, Danila MI, Danilla M. Tattoo: inflicted vasculitis? J Clin Rheumatol. 2007 Feb; 13(1):49. PMID: 17278953.
      Citations:    
    85. Jolly M, Patel P. Looking beyond the ordinary: genital lupus. Arthritis Rheum. 2006 Oct 15; 55(5):821-2. PMID: 17013843.
      Citations:    
    86. Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin North Am. 2006 May; 32(2):275-93, v-vi. PMID: 16716880.
      Citations:    
    87. Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005 Sep; 32(9):1706-8. PMID: 16142864.
      Citations:    
    88. Jolly M. Discoid lupus erythematosus after tattoo: Koebner phenomenon. Arthritis Rheum. 2005 Aug 15; 53(4):627. PMID: 16082645.
      Citations:    
    89. Jolly M, Curran JJ. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis. J Clin Rheumatol. 2005 Aug; 11(4):213-5. PMID: 16357759.
      Citations:    
    90. Jolly M. The risk of cardiac events among patients with systemic lupus erythematosus: comment on the article by Costenbader et al. Arthritis Rheum. 2005 Jun 15; 53(3):476. PMID: 15934113.
      Citations:    
    91. Jolly M. Association of rheumatologic disease with preeclampsia. Obstet Gynecol. 2004 Nov; 104(5 Pt 1):1105-6; author reply 1106. PMID: 15516414.
      Citations:    
    92. Jolly M, Curran JJ. Chlamydial infection preceding the development of rheumatoid arthritis: a brief report. Clin Rheumatol. 2004 Oct; 23(5):453-5. PMID: 15459816.
      Citations:    
    93. Jolly M, Curran JJ, Ellman M. Benign angiopathy of the central nervous system. J Clin Rheumatol. 2004 Apr; 10(2):80-2. PMID: 17043471.
      Citations:    
    94. Jolly M, Utset TO. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004; 13(12):924-6. PMID: 15645747.
      Citations:    
    95. Jolly M, Laumann AE, Shea CR, Utset TO. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus. 2004; 13(1):64-9. PMID: 14870920.
      Citations:    
    96. Jolly M, Smaron M, Olsen Utset T, Ellman M. Are isolated antinucleolar antibodies a marker of scleroderma? J Clin Rheumatol. 2003 Oct; 9(5):291-5. PMID: 17041478.
      Citations:    
    97. Jolly M, Curran JJ. Underuse of intra-articular and periarticular corticosteroid injections by primary care physicians: discomfort with the technique. J Clin Rheumatol. 2003 Jun; 9(3):187-92. PMID: 17041456.
      Citations:    
    Jolly's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (302)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _